PRIA's Summary of the new WISeR Model Provider & Supplier Operational Guide from CMS

Nancy Bax • October 21, 2025

WISeR Model Operational Details Addressed by CMS in New Provider and Supplier Operational Guide

As a leader in Reimbursement and Market Access Services for the Medtech industry, PRIA has closely followed developments on CMS’ WISeR (Wasteful and Inappropriate Service Reduction) model. CMS has now released their Provider and Supplier Operational Guide, addressing many key questions from industry stakeholders. 


Our Summary of the Guide


1. CPT and ICD-10 Codes Identifying WISeR Services

  • The WISeR model lists specific CPT, HCPCS, and ICD-10 codes (see Appendices A–C) that define the items and services subject to prior authorization or pre-payment medical review.
  • These codes correspond to procedures like Vagus Nerve Stimulation (VNS), Cervical Fusion, Epidural Steroid Injections, and Percutaneous Vertebral Augmentation, among others.
  • Appendix A identifies covered procedures and CPT/HCPCS codes; Appendix C lists related ICD-10 diagnostic indications. These collectively determine which services fall under WISeR oversight.

2. Refined focus for initial roll out of WISeR

  • Deep Brain Stimulation (DBS) is explicitly excluded from WISeR’s initial phase, as its CPT codes (e.g., 61867, 61868) remain on Medicare’s inpatient-only list. CMS intends to re-evaluate DBS for possible future inclusion.
  • NCD 160.1 will initially focus on nerolytic destruction of the trigeminal nerve
  • NCD 160.7 will initially focus on spinal cord stimulators but will not overlap with CPT codes for spinal neurostimulators. Prior Authorization be being implemented for the permanent implantation procedure.
  • NCD 230.10 will initially focus on mechanical/hydraulic incontinence control devices for the purposes of treating Stress Urinary Incontinence (SUI).
  • NCD 230.18 Prior authorization is being implemented for the permanent, not trial, implantation procedure
  • NCD 230.4 initially will implement prior authorization for the insertion of penile prostheses
  • L39741, L39758, L39793 will initially focus on CPT codes 22554 and 22585

3. Model Participants and Submission Methods

  • WISeR participants are six organizations contracted by CMS in six pilot states (AZ, NJ, OH, OK, TX, WA).
  • Although participants are identified by state, their specific company names are not yet announced.
  • These participants—and their associated Medicare Administrative Contractors (MACs)—will accept prior authorization requests and supporting documentation via fax, mail, esMD (Electronic Submission of Medical Documentation), or electronic portals.

4. CMS/CMMI Authority to Expand WISeR

  • CMS, through the Center for Medicare & Medicaid Innovation (CMMI), has authority under Section 1115A of the Social Security Act to expand the WISeR model to additional services or therapeutic areas during the initial phase.
  • This flexibility allows CMS to add or adjust covered procedures and codes to address new technologies or emerging areas of waste, fraud, and abuse without legislative action.

5. Settings of Care (POS Codes)

  • WISeR applies only to specific settings of care, identified by Place of Service (POS) codes:
  • 11 – Office
  • 12 – Home
  • 19 & 22 – Hospital Outpatient Department
  • 24 – Ambulatory Surgery Center (ASC)
  • These settings define where prior authorization and pre-payment review processes apply. Inpatient services are excluded.


Link to full document on CMS.gov



Notable future events:

 

AMA Webinar - Wed, Oct. 22   – Registration open to the public 


PRIA WISeR Operations Webinar – Week of Nov. 10th

 


Contact PRIA Healthcare to Learn More >>

Click the Icon below to share this with your network

The first in a series on the shifting landscape of patient access
By Chelsy Peet August 20, 2026
The first in a series on the shifting landscape of patient access, from inside the team that fights for the patient's first stamp on their passport.
RAPID and the Long Effort to Close Medicare's Coverage Gap by Tonya Dowd and Sam Murray
By Tonya Dowd & Sam Murray August 17, 2026
FDA authorization does not guarantee timely Medicare coverage. RAPID is CMS’s latest attempt to narrow that gap—and potentially one of its most consequential.
PRIA's webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization
July 28, 2026
PRIAs webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization featuring Dr. Julie Kessel and Dr. Dot Verbrugge
Stop Guessing What FDA Wants by Sam Murray
By Sam Murray June 4, 2026
Stop Guessing What FDA Wants
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough & Beyond
June 3, 2026
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
You Got Your 510(k). Now What?
By Suzy Engwall May 28, 2026
You Got Your 510(k). Now What?
Right Sizing Your Quality System by Sam Murray
By Sam Murray, Head of Regulatory & Quality May 21, 2026
Right Sizing Your Quality System
Cleared for takeoff: Insights from a Medtech First Officer
By Suzy Engwall May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
By Sam Murray, PRIA May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality  - Sam Murray, PRIA
By Sam Murray, Head of Regulatory & Quality May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program
By Tonya Dowd & Sam Murray April 24, 2026
Examining the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier.
MedTech Clinical Evidence Strategy
By PRIA Healthcare April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.